Capha Pharmaceuticals (FPSUF) Financial Statements

Capha Pharmaceuticals's market cap is currently $64.00. The company's EPS TTM is $; its P/E ratio is -14.29; Capha Pharmaceuticals is scheduled to report earnings on December 1, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.